196 related articles for article (PubMed ID: 38019847)
21. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
[TBL] [Abstract][Full Text] [Related]
22. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
Crane AM; Kramer P; Bui JH; Chung WJ; Li XS; Gonzalez-Garay ML; Hawkins F; Liao W; Mora D; Choi S; Wang J; Sun HC; Paschon DE; Guschin DY; Gregory PD; Kotton DN; Holmes MC; Sorscher EJ; Davis BR
Stem Cell Reports; 2015 Apr; 4(4):569-77. PubMed ID: 25772471
[TBL] [Abstract][Full Text] [Related]
23. Targeted replacement of full-length CFTR in human airway stem cells by CRISPR-Cas9 for pan-mutation correction in the endogenous locus.
Vaidyanathan S; Baik R; Chen L; Bravo DT; Suarez CJ; Abazari SM; Salahudeen AA; Dudek AM; Teran CA; Davis TH; Lee CM; Bao G; Randell SH; Artandi SE; Wine JJ; Kuo CJ; Desai TJ; Nayak JV; Sellers ZM; Porteus MH
Mol Ther; 2022 Jan; 30(1):223-237. PubMed ID: 33794364
[TBL] [Abstract][Full Text] [Related]
24. Gene-specific nonsense-mediated mRNA decay targeting for cystic fibrosis therapy.
Kim YJ; Nomakuchi T; Papaleonidopoulou F; Yang L; Zhang Q; Krainer AR
Nat Commun; 2022 May; 13(1):2978. PubMed ID: 35624092
[TBL] [Abstract][Full Text] [Related]
25. Decreased mRNA and protein stability of W1282X limits response to modulator therapy.
Aksit MA; Bowling AD; Evans TA; Joynt AT; Osorio D; Patel S; West N; Merlo C; Sosnay PR; Cutting GR; Sharma N
J Cyst Fibros; 2019 Sep; 18(5):606-613. PubMed ID: 30803905
[TBL] [Abstract][Full Text] [Related]
26. Small-molecule eRF3a degraders rescue CFTR nonsense mutations by promoting premature termination codon readthrough.
Lee RE; Lewis CA; He L; Bulik-Sullivan EC; Gallant SC; Mascenik TM; Dang H; Cholon DM; Gentzsch M; Morton LC; Minges JT; Theile JW; Castle NA; Knowles MR; Kimple AJ; Randell SH
J Clin Invest; 2022 Sep; 132(18):. PubMed ID: 35900863
[TBL] [Abstract][Full Text] [Related]
27. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
[TBL] [Abstract][Full Text] [Related]
28. Suitability of oligonucleotide-mediated cystic fibrosis gene repair in airway epithelial cells.
de Semir D; Nadal M; González JR; Larriba S; Avinyó A; Nunes V; Casals T; Estivill X; Aran JM
J Gene Med; 2003 Jul; 5(7):625-39. PubMed ID: 12825202
[TBL] [Abstract][Full Text] [Related]
29. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
30. Functional restoration of a CFTR splicing mutation through RNA delivery of CRISPR adenine base editor.
Amistadi S; Maule G; Ciciani M; Ensinck MM; De Keersmaecker L; Ramalho AS; Guidone D; Buccirossi M; Galietta LJV; Carlon MS; Cereseto A
Mol Ther; 2023 Jun; 31(6):1647-1660. PubMed ID: 36895161
[TBL] [Abstract][Full Text] [Related]
31. P.F508del editing in cells from cystic fibrosis patients.
Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
[TBL] [Abstract][Full Text] [Related]
32. A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies.
McHugh DR; Steele MS; Valerio DM; Miron A; Mann RJ; LePage DF; Conlon RA; Cotton CU; Drumm ML; Hodges CA
PLoS One; 2018; 13(6):e0199573. PubMed ID: 29924856
[TBL] [Abstract][Full Text] [Related]
33. Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors.
Krishnamurthy S; Traore S; Cooney AL; Brommel CM; Kulhankova K; Sinn PL; Newby GA; Liu DR; McCray PB
Nucleic Acids Res; 2021 Oct; 49(18):10558-10572. PubMed ID: 34520545
[TBL] [Abstract][Full Text] [Related]
34. Investigating REPAIRv2 as a Tool to Edit
Melfi R; Cancemi P; Chiavetta R; Barra V; Lentini L; Di Leonardo A
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640650
[TBL] [Abstract][Full Text] [Related]
35. Induced pluripotent stem cells for treating cystic fibrosis: State of the science.
Pollard BS; Pollard HB
Pediatr Pulmonol; 2018 Nov; 53(S3):S12-S29. PubMed ID: 30062693
[TBL] [Abstract][Full Text] [Related]
36. Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.
Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A
Nat Commun; 2019 Aug; 10(1):3556. PubMed ID: 31391465
[TBL] [Abstract][Full Text] [Related]
37. High-Throughput Screening for Readthrough Modulators of CFTR PTC Mutations.
Liang F; Shang H; Jordan NJ; Wong E; Mercadante D; Saltz J; Mahiou J; Bihler HJ; Mense M
SLAS Technol; 2017 Jun; 22(3):315-324. PubMed ID: 28376702
[TBL] [Abstract][Full Text] [Related]
38. In vivo editing of lung stem cells for durable gene correction in mice.
Sun Y; Chatterjee S; Lian X; Traylor Z; Sattiraju SR; Xiao Y; Dilliard SA; Sung YC; Kim M; Lee SM; Moore S; Wang X; Zhang D; Wu S; Basak P; Wang J; Liu J; Mann RJ; LePage DF; Jiang W; Abid S; Hennig M; Martinez A; Wustman BA; Lockhart DJ; Jain R; Conlon RA; Drumm ML; Hodges CA; Siegwart DJ
Science; 2024 Jun; 384(6701):1196-1202. PubMed ID: 38870301
[TBL] [Abstract][Full Text] [Related]
39. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.
Linde L; Boelz S; Nissim-Rafinia M; Oren YS; Wilschanski M; Yaacov Y; Virgilis D; Neu-Yilik G; Kulozik AE; Kerem E; Kerem B
J Clin Invest; 2007 Mar; 117(3):683-92. PubMed ID: 17290305
[TBL] [Abstract][Full Text] [Related]
40. High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia.
Vaidyanathan S; Salahudeen AA; Sellers ZM; Bravo DT; Choi SS; Batish A; Le W; Baik R; de la O S; Kaushik MP; Galper N; Lee CM; Teran CA; Yoo JH; Bao G; Chang EH; Patel ZM; Hwang PH; Wine JJ; Milla CE; Desai TJ; Nayak JV; Kuo CJ; Porteus MH
Cell Stem Cell; 2020 Feb; 26(2):161-171.e4. PubMed ID: 31839569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
